The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf)
Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF).
Gespeichert in:
| Autor*in: |
Biering-Sørensen, Tor [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Umfang: |
2 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE - Fotouhi, Sakineh ELSEVIER, 2019, official journal of the Heart Failure Society of America and the Japanese Heart Failure Society, New York, NY |
|---|---|
| Übergeordnetes Werk: |
volume:26 ; year:2020 ; number:10 ; pages:2-3 ; extent:2 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.cardfail.2020.09.017 |
|---|
| Katalog-ID: |
ELV051586215 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV051586215 | ||
| 003 | DE-627 | ||
| 005 | 20230624174906.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cardfail.2020.09.017 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica |
| 035 | |a (DE-627)ELV051586215 | ||
| 035 | |a (ELSEVIER)S1071-9164(20)30964-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 670 |q VZ |
| 084 | |a 51.75 |2 bkl | ||
| 100 | 1 | |a Biering-Sørensen, Tor |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| 264 | 1 | |c 2020 | |
| 300 | |a 2 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). | ||
| 700 | 1 | |a Papolos, Alexander |4 oth | |
| 700 | 1 | |a Teerlink, John R. |4 oth | |
| 700 | 1 | |a Felker, G. Michael |4 oth | |
| 700 | 1 | |a McMurray, John J.V. |4 oth | |
| 700 | 1 | |a Legg, Jason C. |4 oth | |
| 700 | 1 | |a Malik, Fady I. |4 oth | |
| 700 | 1 | |a Honarpour, Narimon |4 oth | |
| 700 | 1 | |a Kurtz, Christopher E. |4 oth | |
| 700 | 1 | |a Solomon, Scott D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Fotouhi, Sakineh ELSEVIER |t Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE |d 2019 |d official journal of the Heart Failure Society of America and the Japanese Heart Failure Society |g New York, NY |w (DE-627)ELV002771764 |
| 773 | 1 | 8 | |g volume:26 |g year:2020 |g number:10 |g pages:2-3 |g extent:2 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cardfail.2020.09.017 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 51.75 |j Verbundwerkstoffe |j Schichtstoffe |q VZ |
| 951 | |a AR | ||
| 952 | |d 26 |j 2020 |e 10 |h 2-3 |g 2 |y 26.2020, 10, S2-, (2 S.) | ||
| author_variant |
t b s tbs |
|---|---|
| matchkey_str |
bieringsrensentorpapolosalexanderteerlin:2020----:hefcoteadamoiatvtrmcmimcriorgtetiuasrcuenfntoicr |
| hierarchy_sort_str |
2020 |
| bklnumber |
51.75 |
| publishDate |
2020 |
| allfields |
10.1016/j.cardfail.2020.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica (DE-627)ELV051586215 (ELSEVIER)S1071-9164(20)30964-7 DE-627 ger DE-627 rakwb eng 670 VZ 51.75 bkl Biering-Sørensen, Tor verfasserin aut The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) 2020 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). Papolos, Alexander oth Teerlink, John R. oth Felker, G. Michael oth McMurray, John J.V. oth Legg, Jason C. oth Malik, Fady I. oth Honarpour, Narimon oth Kurtz, Christopher E. oth Solomon, Scott D. oth Enthalten in Elsevier Fotouhi, Sakineh ELSEVIER Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE 2019 official journal of the Heart Failure Society of America and the Japanese Heart Failure Society New York, NY (DE-627)ELV002771764 volume:26 year:2020 number:10 pages:2-3 extent:2 https://doi.org/10.1016/j.cardfail.2020.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.75 Verbundwerkstoffe Schichtstoffe VZ AR 26 2020 10 2-3 2 26.2020, 10, S2-, (2 S.) |
| spelling |
10.1016/j.cardfail.2020.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica (DE-627)ELV051586215 (ELSEVIER)S1071-9164(20)30964-7 DE-627 ger DE-627 rakwb eng 670 VZ 51.75 bkl Biering-Sørensen, Tor verfasserin aut The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) 2020 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). Papolos, Alexander oth Teerlink, John R. oth Felker, G. Michael oth McMurray, John J.V. oth Legg, Jason C. oth Malik, Fady I. oth Honarpour, Narimon oth Kurtz, Christopher E. oth Solomon, Scott D. oth Enthalten in Elsevier Fotouhi, Sakineh ELSEVIER Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE 2019 official journal of the Heart Failure Society of America and the Japanese Heart Failure Society New York, NY (DE-627)ELV002771764 volume:26 year:2020 number:10 pages:2-3 extent:2 https://doi.org/10.1016/j.cardfail.2020.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.75 Verbundwerkstoffe Schichtstoffe VZ AR 26 2020 10 2-3 2 26.2020, 10, S2-, (2 S.) |
| allfields_unstemmed |
10.1016/j.cardfail.2020.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica (DE-627)ELV051586215 (ELSEVIER)S1071-9164(20)30964-7 DE-627 ger DE-627 rakwb eng 670 VZ 51.75 bkl Biering-Sørensen, Tor verfasserin aut The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) 2020 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). Papolos, Alexander oth Teerlink, John R. oth Felker, G. Michael oth McMurray, John J.V. oth Legg, Jason C. oth Malik, Fady I. oth Honarpour, Narimon oth Kurtz, Christopher E. oth Solomon, Scott D. oth Enthalten in Elsevier Fotouhi, Sakineh ELSEVIER Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE 2019 official journal of the Heart Failure Society of America and the Japanese Heart Failure Society New York, NY (DE-627)ELV002771764 volume:26 year:2020 number:10 pages:2-3 extent:2 https://doi.org/10.1016/j.cardfail.2020.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.75 Verbundwerkstoffe Schichtstoffe VZ AR 26 2020 10 2-3 2 26.2020, 10, S2-, (2 S.) |
| allfieldsGer |
10.1016/j.cardfail.2020.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica (DE-627)ELV051586215 (ELSEVIER)S1071-9164(20)30964-7 DE-627 ger DE-627 rakwb eng 670 VZ 51.75 bkl Biering-Sørensen, Tor verfasserin aut The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) 2020 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). Papolos, Alexander oth Teerlink, John R. oth Felker, G. Michael oth McMurray, John J.V. oth Legg, Jason C. oth Malik, Fady I. oth Honarpour, Narimon oth Kurtz, Christopher E. oth Solomon, Scott D. oth Enthalten in Elsevier Fotouhi, Sakineh ELSEVIER Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE 2019 official journal of the Heart Failure Society of America and the Japanese Heart Failure Society New York, NY (DE-627)ELV002771764 volume:26 year:2020 number:10 pages:2-3 extent:2 https://doi.org/10.1016/j.cardfail.2020.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.75 Verbundwerkstoffe Schichtstoffe VZ AR 26 2020 10 2-3 2 26.2020, 10, S2-, (2 S.) |
| allfieldsSound |
10.1016/j.cardfail.2020.09.017 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica (DE-627)ELV051586215 (ELSEVIER)S1071-9164(20)30964-7 DE-627 ger DE-627 rakwb eng 670 VZ 51.75 bkl Biering-Sørensen, Tor verfasserin aut The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) 2020 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). Papolos, Alexander oth Teerlink, John R. oth Felker, G. Michael oth McMurray, John J.V. oth Legg, Jason C. oth Malik, Fady I. oth Honarpour, Narimon oth Kurtz, Christopher E. oth Solomon, Scott D. oth Enthalten in Elsevier Fotouhi, Sakineh ELSEVIER Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE 2019 official journal of the Heart Failure Society of America and the Japanese Heart Failure Society New York, NY (DE-627)ELV002771764 volume:26 year:2020 number:10 pages:2-3 extent:2 https://doi.org/10.1016/j.cardfail.2020.09.017 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.75 Verbundwerkstoffe Schichtstoffe VZ AR 26 2020 10 2-3 2 26.2020, 10, S2-, (2 S.) |
| language |
English |
| source |
Enthalten in Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE New York, NY volume:26 year:2020 number:10 pages:2-3 extent:2 |
| sourceStr |
Enthalten in Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE New York, NY volume:26 year:2020 number:10 pages:2-3 extent:2 |
| format_phy_str_mv |
Article |
| bklname |
Verbundwerkstoffe Schichtstoffe |
| institution |
findex.gbv.de |
| dewey-raw |
670 |
| isfreeaccess_bool |
false |
| container_title |
Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE |
| authorswithroles_txt_mv |
Biering-Sørensen, Tor @@aut@@ Papolos, Alexander @@oth@@ Teerlink, John R. @@oth@@ Felker, G. Michael @@oth@@ McMurray, John J.V. @@oth@@ Legg, Jason C. @@oth@@ Malik, Fady I. @@oth@@ Honarpour, Narimon @@oth@@ Kurtz, Christopher E. @@oth@@ Solomon, Scott D. @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002771764 |
| dewey-sort |
3670 |
| id |
ELV051586215 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV051586215</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624174906.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cardfail.2020.09.017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV051586215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1071-9164(20)30964-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Biering-Sørensen, Tor</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF).</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Papolos, Alexander</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teerlink, John R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Felker, G. Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McMurray, John J.V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Legg, Jason C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malik, Fady I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Honarpour, Narimon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kurtz, Christopher E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Solomon, Scott D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Fotouhi, Sakineh ELSEVIER</subfield><subfield code="t">Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE</subfield><subfield code="d">2019</subfield><subfield code="d">official journal of the Heart Failure Society of America and the Japanese Heart Failure Society</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV002771764</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:2-3</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cardfail.2020.09.017</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.75</subfield><subfield code="j">Verbundwerkstoffe</subfield><subfield code="j">Schichtstoffe</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2020</subfield><subfield code="e">10</subfield><subfield code="h">2-3</subfield><subfield code="g">2</subfield><subfield code="y">26.2020, 10, S2-, (2 S.)</subfield></datafield></record></collection>
|
| author |
Biering-Sørensen, Tor |
| spellingShingle |
Biering-Sørensen, Tor ddc 670 bkl 51.75 The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| authorStr |
Biering-Sørensen, Tor |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002771764 |
| format |
electronic Article |
| dewey-ones |
670 - Manufacturing |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
670 VZ 51.75 bkl The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| topic |
ddc 670 bkl 51.75 |
| topic_unstemmed |
ddc 670 bkl 51.75 |
| topic_browse |
ddc 670 bkl 51.75 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a p ap j r t jr jrt g m f gm gmf j j m jj jjm j c l jc jcl f i m fi fim n h nh c e k ce cek s d s sd sds |
| hierarchy_parent_title |
Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE |
| hierarchy_parent_id |
ELV002771764 |
| dewey-tens |
670 - Manufacturing |
| hierarchy_top_title |
Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002771764 |
| title |
The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| ctrlnum |
(DE-627)ELV051586215 (ELSEVIER)S1071-9164(20)30964-7 |
| title_full |
The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| author_sort |
Biering-Sørensen, Tor |
| journal |
Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE |
| journalStr |
Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
2 |
| author_browse |
Biering-Sørensen, Tor |
| container_volume |
26 |
| physical |
2 |
| class |
670 VZ 51.75 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Biering-Sørensen, Tor |
| doi_str_mv |
10.1016/j.cardfail.2020.09.017 |
| dewey-full |
670 |
| title_sort |
effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (cosmic-hf) |
| title_auth |
The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| abstract |
Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). |
| abstractGer |
Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). |
| abstract_unstemmed |
Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF). |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
10 |
| title_short |
The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf) |
| url |
https://doi.org/10.1016/j.cardfail.2020.09.017 |
| remote_bool |
true |
| author2 |
Papolos, Alexander Teerlink, John R. Felker, G. Michael McMurray, John J.V. Legg, Jason C. Malik, Fady I. Honarpour, Narimon Kurtz, Christopher E. Solomon, Scott D. |
| author2Str |
Papolos, Alexander Teerlink, John R. Felker, G. Michael McMurray, John J.V. Legg, Jason C. Malik, Fady I. Honarpour, Narimon Kurtz, Christopher E. Solomon, Scott D. |
| ppnlink |
ELV002771764 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.cardfail.2020.09.017 |
| up_date |
2024-07-06T20:40:22.869Z |
| _version_ |
1803863639059333120 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV051586215</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624174906.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cardfail.2020.09.017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001920.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV051586215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1071-9164(20)30964-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Biering-Sørensen, Tor</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Right Ventricular Structure and Function in Chronic Systolic Heart Failure (cosmic-hf)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Omecamtiv mecarbil (OM) is a cardiac myotrope which selectively activates cardiac myosin and thereby increases cardiac contractility. The aim of the current study was to determine the effect of therapy with OM on right ventricular (RV) structure and function in patients with heart failure (HF).</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Papolos, Alexander</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teerlink, John R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Felker, G. Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McMurray, John J.V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Legg, Jason C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malik, Fady I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Honarpour, Narimon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kurtz, Christopher E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Solomon, Scott D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Fotouhi, Sakineh ELSEVIER</subfield><subfield code="t">Investigating polyethersulfone interleaved Glass/Carbon hybrid composite under impact and its comparison with GLARE</subfield><subfield code="d">2019</subfield><subfield code="d">official journal of the Heart Failure Society of America and the Japanese Heart Failure Society</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV002771764</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:2-3</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cardfail.2020.09.017</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.75</subfield><subfield code="j">Verbundwerkstoffe</subfield><subfield code="j">Schichtstoffe</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2020</subfield><subfield code="e">10</subfield><subfield code="h">2-3</subfield><subfield code="g">2</subfield><subfield code="y">26.2020, 10, S2-, (2 S.)</subfield></datafield></record></collection>
|
| score |
7.397687 |